Surgery Partners ROA 2013-2025 | SGRY
Current and historical return on assets (ROA) values for Surgery Partners (SGRY) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Surgery Partners ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-03-31 | $-0.20B | $7.95B | -2.53% |
| 2024-12-31 | $-0.17B | $7.89B | -2.26% |
| 2024-09-30 | $-0.06B | $7.53B | -0.84% |
| 2024-06-30 | $-0.03B | $7.49B | -0.48% |
| 2024-03-31 | $0.00B | $6.98B | 0.01% |
| 2023-12-31 | $-0.01B | $6.88B | -0.18% |
| 2023-09-30 | $-0.03B | $6.78B | -0.51% |
| 2023-06-30 | $-0.05B | $6.62B | -0.82% |
| 2023-03-31 | $-0.09B | $6.64B | -1.39% |
| 2022-12-31 | $-0.05B | $6.68B | -0.84% |
| 2022-09-30 | $-0.03B | $6.54B | -0.49% |
| 2022-06-30 | $-0.03B | $6.29B | -0.48% |
| 2022-03-31 | $-0.04B | $6.29B | -0.64% |
| 2021-12-31 | $-0.08B | $6.12B | -1.41% |
| 2021-09-30 | $-0.09B | $5.63B | -1.54% |
| 2021-06-30 | $-0.14B | $5.62B | -2.46% |
| 2021-03-31 | $-0.15B | $5.64B | -2.78% |
| 2020-12-31 | $-0.16B | $5.41B | -2.96% |
| 2020-09-30 | $-0.18B | $5.31B | -3.48% |
| 2020-06-30 | $-0.13B | $5.25B | -2.62% |
| 2020-03-31 | $-0.12B | $5.09B | -2.41% |
| 2019-12-31 | $-0.11B | $5.02B | -2.27% |
| 2019-09-30 | $-0.24B | $4.92B | -4.94% |
| 2019-06-30 | $-0.24B | $4.89B | -5.11% |
| 2019-03-31 | $-0.24B | $4.88B | -5.16% |
| 2018-12-31 | $-0.24B | $4.68B | -5.15% |
| 2018-09-30 | $-0.12B | $4.56B | -2.64% |
| 2018-06-30 | $-0.12B | $4.58B | -2.70% |
| 2018-03-31 | $-0.10B | $4.60B | -2.45% |
| 2017-12-31 | $-0.08B | $4.62B | -2.23% |
| 2017-09-30 | $-0.02B | $4.60B | -0.74% |
| 2017-06-30 | $0.01B | $2.67B | 0.34% |
| 2017-03-31 | $0.01B | $2.29B | 0.62% |
| 2016-12-31 | $0.01B | $2.31B | 0.45% |
| 2016-09-30 | $0.01B | $2.25B | 0.46% |
| 2016-06-30 | $0.01B | $2.21B | 0.43% |
| 2016-03-31 | $0.00B | $2.20B | 0.13% |
| 2015-12-31 | $0.00B | $2.10B | 0.20% |
| 2015-06-30 | $-0.02B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.473B | $3.114B |
| Surgery Partners, Inc. is a healthcare services company. The Company's outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment and Optical Services segment. Surgery Partners, Inc. is based in Nashville, Tennessee. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.550B | 26.36 |
| Elevance Health (ELV) | United States | $84.617B | 10.92 |
| CVS Health (CVS) | United States | $84.212B | 10.47 |
| Cencora (COR) | United States | $56.918B | 19.80 |
| Natera (NTRA) | United States | $23.467B | 0.00 |
| DiDi Global (DIDIY) | China | $22.356B | 23.75 |
| Labcorp Holdings (LH) | United States | $21.919B | 17.78 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.557B | 0.00 |
| Solventum (SOLV) | United States | $12.729B | 13.47 |
| CochLear (CHEOY) | Australia | $12.142B | 0.00 |
| ICON (ICLR) | Ireland | $11.829B | 11.00 |
| Revvity (RVTY) | United States | $11.196B | 19.27 |
| Doximity (DOCS) | United States | $10.774B | 49.88 |
| Viatris (VTRS) | United States | $10.411B | 3.58 |
| Avantor (AVTR) | United States | $9.247B | 13.44 |
| Medpace Holdings (MEDP) | United States | $8.892B | 23.62 |
| HealthEquity (HQY) | United States | $8.760B | 38.37 |
| Sonic Healthcare (SKHHY) | Australia | $8.172B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.242B | 14.19 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.149B | 24.44 |
| BrightSpring Health Services (BTSG) | United States | $3.915B | 35.92 |
| Sotera Health (SHC) | United States | $3.233B | 18.37 |
| Alignment Healthcare (ALHC) | United States | $2.762B | 0.00 |
| Concentras Parent (CON) | United States | $2.658B | 15.36 |
| Organon (OGN) | United States | $2.535B | 2.69 |
| PACS (PACS) | United States | $2.009B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.912B | 73.63 |
| Ardent Health (ARDT) | United States | $1.865B | 7.95 |
| Premier (PINC) | United States | $1.816B | 13.79 |
| Progyny (PGNY) | United States | $1.798B | 39.58 |
| GoodRx Holdings (GDRX) | United States | $1.643B | 32.86 |
| Teladoc Health (TDOC) | United States | $1.211B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.136B | 8.64 |
| Establishment Labs Holdings (ESTA) | $1.093B | 0.00 | |
| CareDx (CDNA) | United States | $1.060B | 16.56 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.999B | 0.00 |
| Agilon Health (AGL) | United States | $0.873B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.839B | 7.85 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| LifeMD (LFMD) | United States | $0.671B | 0.00 |
| Nutex Health (NUTX) | United States | $0.633B | 9.58 |
| Embecta (EMBC) | United States | $0.571B | 3.85 |
| InnovAge Holding (INNV) | United States | $0.525B | 0.00 |
| Enhabit (EHAB) | United States | $0.469B | 38.63 |
| Auna S.A (AUNA) | Luxembourg | $0.460B | 10.35 |
| Sonida Senior Living (SNDA) | United States | $0.452B | 0.00 |
| SBC Medicals (SBC) | United States | $0.447B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.433B | 0.00 |
| Omada Health (OMDA) | $0.391B | 0.00 | |
| Performant Healthcare (PHLT) | United States | $0.269B | 0.00 |
| Oncology Institute (TOI) | United States | $0.213B | 0.00 |
| Beauty Health (SKIN) | United States | $0.203B | 0.00 |
| DocGo (DCGO) | United States | $0.162B | 26.50 |
| Pheton Holdings (PTHL) | China | $0.128B | 0.00 |
| So-Young (SY) | China | $0.119B | 0.00 |
| KindlyMD (NAKA) | United States | $0.086B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.072B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.053B | 0.00 |
| ModivCare (MODV) | United States | $0.047B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.045B | 0.00 |
| Biodesix (BDSX) | United States | $0.038B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |